Cdk1 Inhibitors
Items 11 to 20 of 26 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AZD 5438 | 602306-29-6 | sc-361115 sc-361115A | 10 mg 50 mg | $205.00 $865.00 | ||
AZD 5438 (CAS 602306-29-6) acts as a Cdk1 inhibitor, influencing cell cycle progression by modulating Cdk1 activity during essential cellular phases. | ||||||
Indirubin-3′-monoxime | 160807-49-8 | sc-202660 sc-202660A sc-202660B | 1 mg 5 mg 50 mg | $77.00 $315.00 $658.00 | 1 | |
Indirubin-3'-monoxime (CAS 160807-49-8) serves as a Cdk1 inhibitor, impacting cell cycle progression by targeting and modulating Cdk1 activity during crucial cellular phases. | ||||||
PHA 767491 hydrochloride | 942425-68-5 | sc-204187 sc-204187A | 10 mg 50 mg | $194.00 $786.00 | 3 | |
This compound is a selective CDK1 inhibitor that has been used to study CDK1-mediated processes in cell cycle regulation. | ||||||
Olomoucine II | 500735-47-7 | sc-202750 sc-202750A | 1 mg 5 mg | $138.00 $204.00 | ||
Olomoucine II (CAS 500735-47-7) acts as a Cdk1 inhibitor, influencing cell cycle progression by modulating Cdk1 activity during essential cellular phases. | ||||||
5-Iodo-Indirubin-3′-monoxime | sc-221754 | 1 mg | $106.00 | |||
5-Iodo-Indirubin-3'-monoxime serves as a Cdk1 inhibitor, impacting cell cycle progression by targeting and modulating Cdk1 activity during essential cellular phases. | ||||||
Oxindole I | sc-222104 | 10 mg | $273.00 | 2 | ||
Oxindole I acts as a Cdk1 inhibitor, influencing cell cycle progression by modulating Cdk1 activity during essential cellular phases. | ||||||
Cdk1/5 Inhibitor | 40254-90-8 | sc-202094 sc-202094A sc-202094B | 1 mg 5 mg 10 mg | $61.00 $204.00 $367.00 | 2 | |
Cdk1/5 Inhibitor (CAS 40254-90-8) serves as a dual inhibitor of Cdk1 and Cdk5, impacting cell cycle progression by modulating the activities of these key regulatory kinases during essential cellular phases. | ||||||
Butyrolactone I | 87414-49-1 | sc-201533 sc-201533A | 200 µg 1 mg | $120.00 $504.00 | 1 | |
Butyrolactone I (CAS 87414-49-1) functions as a Cdk1 inhibitor, influencing cell cycle progression by targeting and modulating Cdk1 activity during crucial cellular phases. | ||||||
N9-Isopropyl-olomoucine | 158982-15-1 | sc-202264 sc-202264A | 1 mg 5 mg | $181.00 $650.00 | 1 | |
N9-Isopropyl-olomoucine (CAS 158982-15-1) acts as a Cdk1 inhibitor, influencing cell cycle progression by targeting and modulating Cdk1 activity during essential cellular phases. | ||||||
NU2058 | 161058-83-9 | sc-202744 sc-202744A | 5 mg 25 mg | $66.00 $321.00 | 2 | |
NU2058 (CAS 161058-83-9) serves as a Cdk1 inhibitor, impacting cell cycle progression by modulating Cdk1 activity during essential cellular phases. | ||||||